US$ 25.70
louisiana glp-1 gastroparesis class action Lawsuit Against Ozempic Manufacturers Claims Side Effects Were Not Adequately Disclosed on Drug Label glp-1 gastroparesis lawyer in louisiana
Description
Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Bonus - Semaglutide has the added benefit of aiding weight loss and supporting better glycaemic control in T2 Diabetes (as well as all of the other benefits that this wonder drug is capable of)

Lemon balm is a culinary herb with mild metabolic benefits, while Ozempic is a prescription GLP-1 receptor agonist that produces significant weight loss through appetite suppression

Joel Habener, Lotte Bjerre Knudsen, Svetlana Mojsov
